Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
2 drugs in development
By Therapeutic Area
top 2
R&D Momentum
18/100
Pipeline Velocity
6/100
Trial Completion Rate
100/100
Pipeline Concentration
38/100
Pipeline Freshness
73/100
Strategic Signals
Activity
Last 14 days
Comparison of Chlorhexidine, Green Tea, and White Tea Oral Care for the Prevention of Ventilator- Associated Pneumonia in Mechanically Ventilated Patients
EFFECTIVENESS OF SPIRITUAL CARE COUNSELING TRAINING GIVEN TO NURSES ON SPIRITUAL WELL-BEING, SPIRITUAL CARE PERCEPTIONS, AND SPIRITUAL CARE COMPETENCIES
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)